Royalty Pharma Plc (RPRX)
64.76
+0.90
(+1.41%)
USD |
NASDAQ |
Oct 26, 16:00
64.88
+0.12
(+0.19%)
After-Hours: 18:30
Royalty Pharma Gross Profit Margin (Quarterly) : 99.81% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 99.81% |
| March 31, 2026 | 99.81% |
| December 31, 2025 | 99.81% |
| September 30, 2025 | 99.79% |
| June 30, 2025 | 0.00% |
| March 31, 2025 | 0.00% |
| December 31, 2024 | 0.00% |
| September 30, 2024 | 0.00% |
| June 30, 2024 | 0.00% |
| March 31, 2024 | 0.00% |
| December 31, 2023 | 0.00% |
| September 30, 2023 | 0.00% |
| June 30, 2023 | 0.00% |
| March 31, 2023 | 0.00% |
| December 31, 2022 | 0.00% |
| Date | Value |
|---|---|
| September 30, 2022 | 0.00% |
| June 30, 2022 | 0.00% |
| March 31, 2022 | 98.99% |
| December 31, 2021 | 98.96% |
| September 30, 2021 | 0.00% |
| June 30, 2021 | 0.00% |
| March 31, 2021 | 0.00% |
| December 31, 2020 | 0.00% |
| September 30, 2020 | 0.00% |
| June 30, 2020 | 0.00% |
| March 31, 2020 | 0.00% |
| December 31, 2019 | 0.00% |
| September 30, 2019 | 0.00% |
| June 30, 2019 | 0.00% |
| March 31, 2019 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Merck & Co., Inc. | 71.51% |
| Johnson & Johnson | 68.11% |
| ANI Pharmaceuticals, Inc. | 54.97% |
| Corcept Therapeutics, Inc. | 98.41% |
| Veru, Inc. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 13.90% |
| Return on Assets | 6.96% |
| Return on Invested Capital | 7.30% |
| Profit Margin (Quarterly) | 12.09% |
| Operating Margin (Quarterly) | 19.75% |
| Return on Net Operating Assets | 7.60% |